The goals of the study are to prove the safety and efficacy of transfusion of hepatitis B immune plasma (HBIP). Liver transplant patients infected with HBV will receive 100ml of HBIP at monthly intervals. A total of 12 patients per year are estimated to receive this treatment. Pretransfusion serum specimens will be collected and sent to Dr. Vyas' laboratory.
Showing the most recent 10 out of 634 publications